chromID™ MRSA /SAID - Chromogenic medium for the screening and - BIOMERIEUX SA

Duns Number:276816717

Device Description: Chromogenic medium for the screening and qualitative detection of methicillin-resistant St Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus and selective isolation of staphylococci and the direct identification of S. aureus.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

chromID™ MRSA /SAID

Version/Model Number

chromID™ MRSA /SAID

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K151688,K162076,K151688,K162076,K151688,K162076

Product Code Details

Product Code

JSO

Product Code Name

Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar

Device Record Status

Public Device Record Key

06e8cd8d-c755-48ed-9b57-b1fb33121444

Public Version Date

February 06, 2020

Public Version Number

5

DI Record Publish Date

September 16, 2016

Additional Identifiers

Package DI Number

03573026420758

Quantity per Package

2

Contains DI Package

03573026552091

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

-

"BIOMERIEUX SA" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 82
2 A medical device with a moderate to high risk that requires special controls. 156
3 A medical device with high risk that requires premarket approval 3